excellent

Scancell reports Phase 2 data showing strongly improved outcomes in Late-Stage Melanoma with its Immunobody iSCIB1+

July 22, 2025 02:00 ET  | Source: Scancell Holdings Plc SCOPE trial of SCIB1/iSCIB1+ plus standard of care shows excellent…

4 days ago

Five-year Pharmacovigilance study by NTC confirms safety of fixed-dose eye drops for Post-cataract Surgery

MILAN, July 17, 2025 /PRNewswire/ -- A recently published five-year pharmacovigilance study confirms the excellent safety profile of a fixed-dose combination…

1 week ago

QS Best Student Cities Ranking 2026

London slips, Seoul crowned #1, Asia rises LONDON, July 15, 2025 /PRNewswire/ -- Seoul is crowned the world's best study…

2 weeks ago

Microban International Unveils H2O Shield, a Portfolio of PFAS-Free Water-Resistant Textile Technologies

Tailored solutions provide excellent water repellency while addressing key concerns such as fabric chalk mark defects and seam slippage HUNTERSVILLE,…

2 months ago